BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19528475)

  • 1. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
    Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype.
    Zhao H; Tang H; Xiao Q; He M; Zhao L; Fu Y; Wu H; Yu Z; Jiang Q; Yan Y; Jin F; Wei M
    Mol Med Rep; 2016 Dec; 14(6):5261-5270. PubMed ID: 27779682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
    Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of breast cancer stem cells and the expression of key molecules in Hedgehog signaling pathway].
    Lu ZH; Jia J; Ren J; Ma B; DI LJ; Song GH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):480-5. PubMed ID: 18931709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
    Xu Y; An Y; Wang X; Zha W; Li X
    Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
    Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
    Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
    Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
    Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
    Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.
    Kameda C; Tanaka H; Yamasaki A; Nakamura M; Koga K; Sato N; Kubo M; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2009 Mar; 29(3):871-9. PubMed ID: 19414322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
    Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
    Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells.
    Suyama K; Onishi H; Imaizumi A; Shinkai K; Umebayashi M; Kubo M; Mizuuchi Y; Oda Y; Tanaka M; Nakamura M; Katano M
    Cancer Lett; 2016 Apr; 374(1):44-53. PubMed ID: 26797459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
    Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
    Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro.
    Vestergaard J; Pedersen MW; Pedersen N; Ensinger C; Tümer Z; Tommerup N; Poulsen HS; Larsen LA
    Lung Cancer; 2006 Jun; 52(3):281-90. PubMed ID: 16616798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.
    Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS
    Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.
    Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M
    Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
    Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.